Article(id=1326652279614189861, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1326652135099445330, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2025.09.017, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1741881600000, receivedDateStr=2025-03-14, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1794228151466, onlineDateStr=2026-11-09, pubDate=1757433600000, pubDateStr=2025-09-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1794228151466, onlineIssueDateStr=2026-11-09, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1794228151466, creator=13701087609, updateTime=1794228151466, updator=13701087609, issue=Issue{id=1326652135099445330, tenantId=1146029695717560320, journalId=1319690329412173987, year='2025', volume='46', issue='9', pageStart='869', pageEnd='998', issueExtLink='null', onlineDate='null', pubDate='1757433600000', pubDateStr='2025-09-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1794228117011, creator='13701087609', updateTime=1794272950571, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1326840181111501690, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1326652135099445330, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1326840181111501691, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1326652135099445330, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=978, endPage=983, ext={EN=ArticleExt(id=1326652279802933542, articleId=1326652279614189861, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=Research progress on drug development for non-alcoholic fatty liver disease, columnId=1325221194584162830, journalTitle=World Clinical Drug, columnName=Review, runingTitle=null, highlight=null, articleAbstract=

Non-alcoholic fatty liver disease(NAFLD) has become one of the most prevalent chronic liver diseases worldwide, with its incidence rising rapidly alongside the increasing prevalence of obesity and metabolic syndrome. At present, the treatment of NAFLD mainly relies on lifestyle intervention, but there is a lack of specific drugs. With in-depth research into the pathophysiological mechanisms of NAFLD, multiple drugs target metabolic disorders, inflammation, and fibrosis have become a hot topic. This article reviewed the latest advancements in NAFLD drug development, statistically analyzed global research trends and therapeutic hotspots, focused on introducing the clinical trial outcomes of metabolic modulators, anti-inflammatory or anti-fibrotic agents, and emerging targets, and discussed the future directions in this field.

, authors=Li'na CHEN, Hongling MA, Keran WANG, Lixin ZHANG, Guleng Siri*, authorsList=Li'na CHEN, Hongling MA, Keran WANG, Lixin ZHANG, Guleng Siri, authorCompany=null, correspAuthors=Guleng Siri, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1326652280079757607, articleId=1326652279614189861, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=非酒精性脂肪性肝病药物研发进展, columnId=1325221194743546384, journalTitle=世界临床药物, columnName=综述评论, runingTitle=null, highlight=null, articleAbstract=

非酒精性脂肪性肝病(non-alcoholic fatty liver disease,NAFLD)已成为全球常见的慢性肝病之一,其发病率随肥胖和代谢综合征的发病率增加迅速上升。目前,NAFLD的治疗多以生活方式干预为主,但缺乏特效药物。随着对NAFLD病理生理机制研究的深入,针对代谢紊乱、炎症和纤维化的多种靶点药物成为热点。该文对NAFLD药物研发的最新进展进行综述,统计分析NAFLD全球研究趋势及治疗热点,重点介绍代谢调节剂、抗炎和抗纤维化药物以及新兴靶点的临床试验结果,并探讨NAFLD未来研发方向。

, authors=陈丽娜, 马红玲, 王科冉, 张丽新, 斯日古楞*, authorsList=陈丽娜, 马红玲, 王科冉, 张丽新, 斯日古楞, authorCompany=null, correspAuthors=斯日古楞, authorNote=

陈丽娜,主管药师,研究方向:临床药学。

, correspAuthorsNote=
斯日古楞,主任药师,研究方向:临床药学及药事管理。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=sFTAIZutXPfMRRg2zxlEWA==, magXml=BSmFGtZECbDw6UosZzPiLQ==, pdfUrl=null, pdf=oTxPbDcKCH3Q6Nm1tu1PYQ==, pdfFileSize=947788, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=FT9l7nMyIdRcUg7aXwefYA==, mapNumber=null, fund=null)}, authors=[Author(id=1326652280373358892, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1326652280436273455, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, authorId=1326652280373358892, language=EN, stringName=Li'na CHEN, firstName=Li'na, middleName=null, lastName=CHEN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Pharmacy, Inner Mongolia People's Hospital, Hohhot 010017, Inner Mongolia Autonomous Region, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326652280494993712, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, authorId=1326652280373358892, language=CN, stringName=陈丽娜, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=内蒙古自治区人民医院药学处,内蒙古 呼和浩特 010017, bio={"content":"

陈丽娜,主管药师,研究方向:临床药学。

"}, bioImg=null, bioContent=

陈丽娜,主管药师,研究方向:临床药学。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326652280302055720, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, xref=null, ext=[AuthorCompanyExt(id=1326652280310444329, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, companyId=1326652280302055720, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Pharmacy, Inner Mongolia People's Hospital, Hohhot 010017, Inner Mongolia Autonomous Region, China), AuthorCompanyExt(id=1326652280314638634, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, companyId=1326652280302055720, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=内蒙古自治区人民医院药学处,内蒙古 呼和浩特 010017)])]), Author(id=1326652280553713970, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1326652280620822836, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, authorId=1326652280553713970, language=EN, stringName=Hongling MA, firstName=Hongling, middleName=null, lastName=MA, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Pharmacy, Inner Mongolia People's Hospital, Hohhot 010017, Inner Mongolia Autonomous Region, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326652280692126005, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, authorId=1326652280553713970, language=CN, stringName=马红玲, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=内蒙古自治区人民医院药学处,内蒙古 呼和浩特 010017, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326652280302055720, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, xref=null, ext=[AuthorCompanyExt(id=1326652280310444329, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, companyId=1326652280302055720, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Pharmacy, Inner Mongolia People's Hospital, Hohhot 010017, Inner Mongolia Autonomous Region, China), AuthorCompanyExt(id=1326652280314638634, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, companyId=1326652280302055720, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=内蒙古自治区人民医院药学处,内蒙古 呼和浩特 010017)])]), Author(id=1326652280759234871, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1326652280843120953, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, authorId=1326652280759234871, language=EN, stringName=Keran WANG, firstName=Keran, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Pharmacy, Inner Mongolia People's Hospital, Hohhot 010017, Inner Mongolia Autonomous Region, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326652280901841210, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, authorId=1326652280759234871, language=CN, stringName=王科冉, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=内蒙古自治区人民医院药学处,内蒙古 呼和浩特 010017, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326652280302055720, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, xref=null, ext=[AuthorCompanyExt(id=1326652280310444329, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, companyId=1326652280302055720, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Pharmacy, Inner Mongolia People's Hospital, Hohhot 010017, Inner Mongolia Autonomous Region, China), AuthorCompanyExt(id=1326652280314638634, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, companyId=1326652280302055720, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=内蒙古自治区人民医院药学处,内蒙古 呼和浩特 010017)])]), Author(id=1326652280964755772, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1326652282634088770, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, authorId=1326652280964755772, language=EN, stringName=Lixin ZHANG, firstName=Lixin, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Pharmacy, Inner Mongolia People's Hospital, Hohhot 010017, Inner Mongolia Autonomous Region, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326652282780889411, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, authorId=1326652280964755772, language=CN, stringName=张丽新, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=内蒙古自治区人民医院药学处,内蒙古 呼和浩特 010017, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326652280302055720, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, xref=null, ext=[AuthorCompanyExt(id=1326652280310444329, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, companyId=1326652280302055720, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Pharmacy, Inner Mongolia People's Hospital, Hohhot 010017, Inner Mongolia Autonomous Region, China), AuthorCompanyExt(id=1326652280314638634, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, companyId=1326652280302055720, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=内蒙古自治区人民医院药学处,内蒙古 呼和浩特 010017)])]), Author(id=1326652282852192581, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1326652282931884359, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, authorId=1326652282852192581, language=EN, stringName=Guleng Siri, firstName=Guleng, middleName=null, lastName=Siri, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=Department of Pharmacy, Inner Mongolia People's Hospital, Hohhot 010017, Inner Mongolia Autonomous Region, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326652283019964744, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, authorId=1326652282852192581, language=CN, stringName=斯日古楞, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=内蒙古自治区人民医院药学处,内蒙古 呼和浩特 010017, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326652280302055720, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, xref=null, ext=[AuthorCompanyExt(id=1326652280310444329, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, companyId=1326652280302055720, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Pharmacy, Inner Mongolia People's Hospital, Hohhot 010017, Inner Mongolia Autonomous Region, China), AuthorCompanyExt(id=1326652280314638634, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, companyId=1326652280302055720, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=内蒙古自治区人民医院药学处,内蒙古 呼和浩特 010017)])])], keywords=[Keyword(id=1326652283162571081, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, language=EN, orderNo=1, keyword=non-alcoholic fatty liver disease), Keyword(id=1326652283246457162, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, language=EN, orderNo=2, keyword=research and development of drug), Keyword(id=1326652283326148939, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, language=EN, orderNo=3, keyword=drug target), Keyword(id=1326652283431006540, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, language=CN, orderNo=1, keyword=非酒精性脂肪性肝病), Keyword(id=1326652283493921101, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, language=CN, orderNo=2, keyword=药物研发), Keyword(id=1326652283552641358, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, language=CN, orderNo=3, keyword=药物靶点)], refs=[Reference(id=1326652283833659728, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=SCHAFFNER F, THALER H. Nonalcoholic fatty liver disease[J]. Prog Liver Dis, 1986, 8: 283-298., articleTitle=null, refAbstract=null), Reference(id=1326652283896574289, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=ESLAM M, NEWSOME PN, SARIN SK, et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement[J]. J Hepatol, 2020, 73(1): 202-209., articleTitle=null, refAbstract=null), Reference(id=1326652284018209106, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=ESLAM M, SANYAL AJ, GEORGE J. MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease[J]. Gastroenterology, 2020, 158(7): 1999-2014., articleTitle=null, refAbstract=null), Reference(id=1326652284081123667, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=ESLAM M, SARIN SK, WONG VW, et al. The Asian Pacific Association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease[J]. Hepatol Int, 2020, 14(6):889-919., articleTitle=null, refAbstract=null), Reference(id=1326652284152426836, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=RIAZI K, AZHARI H, CHARETTE JH, et al. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis[J]. Lancet Gastroenterol Hepatol, 2022, 7(9):851-861., articleTitle=null, refAbstract=null), Reference(id=1326652284223730005, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=LE MH, LE DM, BAEZ TC, et al. Global incidence of non-alcoholic fatty liver disease: a systematic review and meta-analysis of 63 studies and 1, 201, 807 persons[J]. J Hepatol, 2023, 79(2): 287-295., articleTitle=null, refAbstract=null), Reference(id=1326652284332781910, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=LOU TW, YANG RX, FAN JG. The global burden of fatty liver disease: the major impact of China[J]. Hepatobiliary Surg Nutr, 2024, 13(1): 119-123., articleTitle=null, refAbstract=null), Reference(id=1326652284395696471, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=LOOMBA R, FRIEDMAN SL, SHULMAN GI. Mechanisms and disease consequences of nonalcoholic fatty liver disease[J]. Cell, 2021, 184(10): 2537-2564., articleTitle=null, refAbstract=null), Reference(id=1326652284483776856, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=FLANNERY C, DUFOUR S, RABOL R, et al. Skeletal muscle insulin resistance promotes increased hepatic de novo lipogenesis, hyperlipidemia, and hepatic steatosis in the elderly[J]. Diabetes, 2012, 61(11): 2711-2717., articleTitle=null, refAbstract=null), Reference(id=1326652284550885721, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=RABOL R, PETERSEN KF, DUFOUR S, et al. Reversal of muscle insulin resistance with exercise reduces postprandial hepatic de novo lipogenesis in insulin resistant individuals[J]. Proc Natl Acad Sci USA, 2011, 108(33): 13705-13709., articleTitle=null, refAbstract=null), Reference(id=1326652284613800282, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=LEUNG C, RIVERA L, FURNESS JB, et al. The role of the gut microbiota in NAFLD[J]. Nat Rev Gastroenterol Hepatol, 2016, 13(7): 412-425., articleTitle=null, refAbstract=null), Reference(id=1326652284722852187, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=赵丽, 罗娟, 陈晶. 肠道微生物群与非酒精性脂肪性肝病的最新研究进展[J]. 胃肠病学和肝病学杂志, 2020, 29(6):700-703., articleTitle=null, refAbstract=null), Reference(id=1326652284789961052, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=DUELL PB, WELTY FK, MILLER M, et al. Nonalcoholic fatty liver disease and cardiovascular risk: a scientific statement from the American Heart Association[J]. Arterioscler Thromb Vasc Biol, 2022, 42(6): e168-e185., articleTitle=null, refAbstract=null), Reference(id=1326652284861264221, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=段蓉, 李正翔. 国内外药物警戒研究现状与热点的文献计量学分析[J]. 中国药房, 2022, 33(1): 116-122., articleTitle=null, refAbstract=null), Reference(id=1326652284911595870, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=董微, 闻育. 基于数据关联性聚类的数据布局算法[J]. 计算机工程与应用, 2014, (3): 117-120., articleTitle=null, refAbstract=null), Reference(id=1326652284978704735, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=KHAZNADAR F, KHAZNADAR O, PETROVIC A, et al. MAFLD pandemic: Updates in pharmacotherapeutic approach development[J]. Curr Issues Mol Biol, 2024, 46(7): 6300-6314., articleTitle=null, refAbstract=null), Reference(id=1326652285050007904, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=BERTHIER A, JOHANNS M, ZUMMO FP, et al. PPARs in liver physiology[J]. Biochim Biophys Acta Mol Basis Dis, 2021, 1867(5): 166097., articleTitle=null, refAbstract=null), Reference(id=1326652285108728161, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=CUSI K, ORSAK B, BRIL F, et al. Long-term pioglitazone treatment for patients with nonalcoholic steatohepatitis and prediabetes or type 2 diabetes mellitus: a randomized trial[J]. Ann Intern Med, 2016, 165(5): 305-315., articleTitle=null, refAbstract=null), Reference(id=1326652285175837026, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=VIOLI F, CANGEMI R. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis[J]. N Engl J Med, 2010,363(12): 1185-1186., articleTitle=null, refAbstract=null), Reference(id=1326652285263917411, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=WANG Z, DU H, ZHAO Y, et al. Response to pioglitazone in non-alcoholic fatty liver disease patients with vs. without type 2 diabetes: a meta-analysis of randomized controlled trials[J]. Front Endocrinol(Lausanne), 2023, 14: 1111430., articleTitle=null, refAbstract=null), Reference(id=1326652285326831972, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=JACQUES V, BOLZE S, HALLAKOU-BOZEC S, et al. Deuterium-stabilized(R)-pioglitazone(PXL065) is responsible for pioglitazone efficacy in NASH yet exhibits little to no PPARγ activity[J]. Hepatol Commun, 2021, 5(8):1412-1425., articleTitle=null, refAbstract=null), Reference(id=1326652285448466789, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=Harrison SA, Thang C, Bolze S, et al. Evaluation of PXL065 -deuterium-stabilized (R)-pioglitazone in patients with NASH: a phase Ⅱ randomized placebo-controlled trial(DESTINY-1)[J]. J Hepatol, 2023, 78(5): 914-925., articleTitle=null, refAbstract=null), Reference(id=1326652287117799784, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=BARB D, KALAVALAPALLI S, GODINEZ LEIVA E, et al. Pan-PPAR agonist lanifibranor improves insulin resistance and hepatic steatosis in patients with T2D and MASLD[J]. J Hepatol, 2025, 82(6): 979-991., articleTitle=null, refAbstract=null), Reference(id=1326652287189102953, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=SOUZA M, AL-SHARIF L, ANTUNES VLJ, et al. Comparison of pharmacological therapies in metabolic dysfunction-associated steatohepatitis for fibrosis regression and MASH resolution: systematic review and network meta-analysis[J]. Hepatology, 2025, doi: 10.1097/HEP.0000000000001254., articleTitle=null, refAbstract=null), Reference(id=1326652287247823210, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=LEFERE S, PUENGEL T, HUNDERTMARK J, et al. Differential effects of selective - and pan-PPAR agonists on experimental steatohepatitis and hepatic macrophages[J]. J Hepatol, 2020, 73(4): 757-770., articleTitle=null, refAbstract=null), Reference(id=1326652287319126379, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=EVANS JL, LIN JJ, GOLDFINE ID. Novel approach to treat insulin resistance, type 2 diabetes, and the metabolic syndrome: simultaneous activation of PPARα, PPARγ, and PPARδ[J]. Curr Diabetes Rev, 2005, 1(3): 299-307., articleTitle=null, refAbstract=null), Reference(id=1326652287428178284, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=XU HR, ZHANG JW, CHEN WL, et al. Pharmacokinetics, safety and tolerability of chiglitazar, a novel peroxisome proliferator-activated receptor(PPAR) pan-agonist, in healthy Chinese volunteers: a phase Ⅰ study[J]. Clin Drug Investig, 2019, 39(6): 553-563., articleTitle=null, refAbstract=null), Reference(id=1326652287491092845, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=SHINOZAKI S, MIURA K, TAHARA T, et al. Effectiveness of pemafibrate dose escalation on metabolic dysfunction-associated steatotic liver disease refractory to standard dose[J]. Metabolites, 2025, 15(2): 100., articleTitle=null, refAbstract=null), Reference(id=1326652287558201710, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=DUTTA D, KAMRUL-HASAN ABM, MONDAL E, et al. Role of resmetirom, a liver-directed, thyroid hormone receptor beta-selective agonist, in managing nonalcoholic steatohepatitis: a systematic review and meta-analysis[J]. Endocr Pract, 2024, 30(7): 631-638., articleTitle=null, refAbstract=null), Reference(id=1326652287612727663, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=HARRISON SA, BEDOSSA P, GUY CD, et al. A phase 3, randomized, controlled trial of resmetirom in nash with liver fibrosis[J]. N Engl J Med, 2024, 390(6): 497-509., articleTitle=null, refAbstract=null), Reference(id=1326652287671447920, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=AU K, ZHENG MH, LEE WJ, et al. Resmetirom and metabolic dysfunction-associated steatohepatitis: Perspectives on multidisciplinary management from global healthcare professionals[J]. Curr Obes Rep, 2024, 13(4): 818-830., articleTitle=null, refAbstract=null), Reference(id=1326652287734362481, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=HAVRANEK B, LOH R, TORRE B, et al. Glucagon-like peptide-1 receptor agonists improve metabolic dysfunction-associated steatotic liver disease outcomes[J]. Sci Rep, 2025,15(1): 4947., articleTitle=null, refAbstract=null), Reference(id=1326652287793082738, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[33], rfOrder=32, authorNames=null, journalName=null, refType=null, unstructuredReference=CORTES-MARTIN A, PLAZA-DIAZ J. Exploring the therapeutic potential of glucagon-like peptide 1 agonists in metabolic disorders[J]. World J Gastroenterol, 2025, 31(4):101436., articleTitle=null, refAbstract=null), Reference(id=1326652287876968819, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[34], rfOrder=33, authorNames=null, journalName=null, refType=null, unstructuredReference=FORMAN BM, GOODE E, CHEN J, et al. Identification of a nuclear receptor that is activated by farnesol metabolites[J]. Cell, 1995, 81(5): 687-693., articleTitle=null, refAbstract=null), Reference(id=1326652287939883380, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[35], rfOrder=34, authorNames=null, journalName=null, refType=null, unstructuredReference=MAKISHIMA M, OKAMOTO AY, REPA JJ, et al. Identification of a nuclear receptor for bile acids[J]. Science,1999, 284(5418): 1362-1365., articleTitle=null, refAbstract=null), Reference(id=1326652288006992245, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[36], rfOrder=35, authorNames=null, journalName=null, refType=null, unstructuredReference=KAMRUL-HASAN A, MONDAL S, NAGENDRA L, et al. Role of obeticholic acid, a farnesoid X receptor agonist, in nonalcoholic fatty liver disease: a systematic review and meta-analysis[J]. touchREV Endocrinol, 2024, 20(2): 54-61., articleTitle=null, refAbstract=null), Reference(id=1326652288069906806, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[37], rfOrder=36, authorNames=null, journalName=null, refType=null, unstructuredReference=MORADI MN, BEHROUJ H, ALIPOOR B, et al. Chlorella vulgaris is an effective supplement in counteracting non-alcoholic fatty liver disease-related complications through modulation of dyslipidemia, insulin resistance, and inflammatory pathways[J]. J Food Biochem, 2021, 45(10):e13914., articleTitle=null, refAbstract=null), Reference(id=1326652288137015671, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[38], rfOrder=37, authorNames=null, journalName=null, refType=null, unstructuredReference=SITUMORANG JH, CHEN MC, KUO WW, et al. 9-POHSA prevents NF-κB activation and ameliorates LPS-induced inflammation in rat hepatocytes[J]. Lipids, 2023, 58(5):241-249., articleTitle=null, refAbstract=null), Reference(id=1326652288225096056, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[39], rfOrder=38, authorNames=null, journalName=null, refType=null, unstructuredReference=JIN X, LIU L, ZHOU Z, et al. Pioglitazone alleviates inflammation in diabetic mice fed a high-fat diet via inhibiting advanced glycation end-product-induced classical macrophage activation[J]. FEBS J, 2016, 283(12): 2295-2308., articleTitle=null, refAbstract=null), Reference(id=1326652288342536569, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[40], rfOrder=39, authorNames=null, journalName=null, refType=null, unstructuredReference=GEERVLIET E, KARKDIJK E, BANSAL R. Inhibition of intrahepatic monocyte recruitment by Cenicriviroc and extracellular matrix degradation by MMP1 synergistically attenuate liver inflammation and fibrogenesis in vivo[J]. Sci Rep, 2024, 14(1): 16897., articleTitle=null, refAbstract=null), Reference(id=1326652288426422650, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[41], rfOrder=40, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHOU M, LV J, CHEN X, et al. From gut to liver: Exploring the crosstalk between gut-liver axis and oxidative stress in metabolic dysfunction-associated steatotic liver disease[J]. Ann Hepatol, 2025, 30(1): 101777., articleTitle=null, refAbstract=null), Reference(id=1326652288493531515, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[42], rfOrder=41, authorNames=null, journalName=null, refType=null, unstructuredReference=BELEI O, OLARIU L, DOBRESCU A, et al. The relationship between non-alcoholic fatty liver disease and small intestinal bacterial overgrowth among overweight and obese children and adolescents[J]. J Pediatr Endocrinol Metab, 2017,30(11): 1161-1168., articleTitle=null, refAbstract=null)], funds=[Fund(id=1326652283720413519, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, awardId=2023GLLH0047, language=CN, fundingSource=公立医院科研联合基金科技项目(2023GLLH0047), fundOrder=null, country=null)], companyList=[AuthorCompany(id=1326652280302055720, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, xref=null, ext=[AuthorCompanyExt(id=1326652280310444329, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, companyId=1326652280302055720, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Pharmacy, Inner Mongolia People's Hospital, Hohhot 010017, Inner Mongolia Autonomous Region, China), AuthorCompanyExt(id=1326652280314638634, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, companyId=1326652280302055720, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=内蒙古自治区人民医院药学处,内蒙古 呼和浩特 010017)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2025.09.017, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2025.09.017, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2025.09.017, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2025.09.017, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1757433600000, fullTextJson=null, articleText=null, reference=null)
收藏切换
非酒精性脂肪性肝病药物研发进展
陈丽娜 , 马红玲 , 王科冉 , 张丽新 , 斯日古楞 *
世界临床药物 | 综述评论 2025,46(9): 978-983
收起
收藏切换
世界临床药物 |综述评论 2025 , 46 (9) : 978 -983
非酒精性脂肪性肝病药物研发进展
全屏
[Author(id=1326652280373358892, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1326652280436273455, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, authorId=1326652280373358892, language=EN, stringName=Li'na CHEN, firstName=Li'na, middleName=null, lastName=CHEN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Pharmacy, Inner Mongolia People's Hospital, Hohhot 010017, Inner Mongolia Autonomous Region, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326652280494993712, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, authorId=1326652280373358892, language=CN, stringName=陈丽娜, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=内蒙古自治区人民医院药学处,内蒙古 呼和浩特 010017, bio={"content":"

陈丽娜,主管药师,研究方向:临床药学。

"}, bioImg=null, bioContent=

陈丽娜,主管药师,研究方向:临床药学。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326652280302055720, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, xref=null, ext=[AuthorCompanyExt(id=1326652280310444329, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, companyId=1326652280302055720, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Pharmacy, Inner Mongolia People's Hospital, Hohhot 010017, Inner Mongolia Autonomous Region, China), AuthorCompanyExt(id=1326652280314638634, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, companyId=1326652280302055720, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=内蒙古自治区人民医院药学处,内蒙古 呼和浩特 010017)])]), Author(id=1326652280553713970, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1326652280620822836, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, authorId=1326652280553713970, language=EN, stringName=Hongling MA, firstName=Hongling, middleName=null, lastName=MA, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Pharmacy, Inner Mongolia People's Hospital, Hohhot 010017, Inner Mongolia Autonomous Region, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326652280692126005, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, authorId=1326652280553713970, language=CN, stringName=马红玲, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=内蒙古自治区人民医院药学处,内蒙古 呼和浩特 010017, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326652280302055720, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, xref=null, ext=[AuthorCompanyExt(id=1326652280310444329, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, companyId=1326652280302055720, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Pharmacy, Inner Mongolia People's Hospital, Hohhot 010017, Inner Mongolia Autonomous Region, China), AuthorCompanyExt(id=1326652280314638634, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, companyId=1326652280302055720, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=内蒙古自治区人民医院药学处,内蒙古 呼和浩特 010017)])]), Author(id=1326652280759234871, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1326652280843120953, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, authorId=1326652280759234871, language=EN, stringName=Keran WANG, firstName=Keran, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Pharmacy, Inner Mongolia People's Hospital, Hohhot 010017, Inner Mongolia Autonomous Region, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326652280901841210, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, authorId=1326652280759234871, language=CN, stringName=王科冉, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=内蒙古自治区人民医院药学处,内蒙古 呼和浩特 010017, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326652280302055720, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, xref=null, ext=[AuthorCompanyExt(id=1326652280310444329, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, companyId=1326652280302055720, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Pharmacy, Inner Mongolia People's Hospital, Hohhot 010017, Inner Mongolia Autonomous Region, China), AuthorCompanyExt(id=1326652280314638634, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, companyId=1326652280302055720, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=内蒙古自治区人民医院药学处,内蒙古 呼和浩特 010017)])]), Author(id=1326652280964755772, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1326652282634088770, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, authorId=1326652280964755772, language=EN, stringName=Lixin ZHANG, firstName=Lixin, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Pharmacy, Inner Mongolia People's Hospital, Hohhot 010017, Inner Mongolia Autonomous Region, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326652282780889411, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, authorId=1326652280964755772, language=CN, stringName=张丽新, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=内蒙古自治区人民医院药学处,内蒙古 呼和浩特 010017, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326652280302055720, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, xref=null, ext=[AuthorCompanyExt(id=1326652280310444329, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, companyId=1326652280302055720, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Pharmacy, Inner Mongolia People's Hospital, Hohhot 010017, Inner Mongolia Autonomous Region, China), AuthorCompanyExt(id=1326652280314638634, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, companyId=1326652280302055720, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=内蒙古自治区人民医院药学处,内蒙古 呼和浩特 010017)])]), Author(id=1326652282852192581, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1326652282931884359, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, authorId=1326652282852192581, language=EN, stringName=Guleng Siri, firstName=Guleng, middleName=null, lastName=Siri, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=Department of Pharmacy, Inner Mongolia People's Hospital, Hohhot 010017, Inner Mongolia Autonomous Region, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326652283019964744, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, authorId=1326652282852192581, language=CN, stringName=斯日古楞, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=内蒙古自治区人民医院药学处,内蒙古 呼和浩特 010017, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326652280302055720, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, xref=null, ext=[AuthorCompanyExt(id=1326652280310444329, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, companyId=1326652280302055720, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Pharmacy, Inner Mongolia People's Hospital, Hohhot 010017, Inner Mongolia Autonomous Region, China), AuthorCompanyExt(id=1326652280314638634, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652279614189861, companyId=1326652280302055720, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=内蒙古自治区人民医院药学处,内蒙古 呼和浩特 010017)])])]
陈丽娜, 马红玲, 王科冉, 张丽新, 斯日古楞*
作者信息
  • 内蒙古自治区人民医院药学处,内蒙古 呼和浩特 010017
通讯作者:
斯日古楞,主任药师,研究方向:临床药学及药事管理。
作者简介:

陈丽娜,主管药师,研究方向:临床药学。

Research progress on drug development for non-alcoholic fatty liver disease
Li'na CHEN, Hongling MA, Keran WANG, Lixin ZHANG, Guleng Siri*
Affiliations
  • Department of Pharmacy, Inner Mongolia People's Hospital, Hohhot 010017, Inner Mongolia Autonomous Region, China
出版时间: 2025-09-10 doi: 10.13683/j.wph.2025.09.017
文章导航
收藏切换

非酒精性脂肪性肝病(non-alcoholic fatty liver disease,NAFLD)已成为全球常见的慢性肝病之一,其发病率随肥胖和代谢综合征的发病率增加迅速上升。目前,NAFLD的治疗多以生活方式干预为主,但缺乏特效药物。随着对NAFLD病理生理机制研究的深入,针对代谢紊乱、炎症和纤维化的多种靶点药物成为热点。该文对NAFLD药物研发的最新进展进行综述,统计分析NAFLD全球研究趋势及治疗热点,重点介绍代谢调节剂、抗炎和抗纤维化药物以及新兴靶点的临床试验结果,并探讨NAFLD未来研发方向。

非酒精性脂肪性肝病  /  药物研发  /  药物靶点

Non-alcoholic fatty liver disease(NAFLD) has become one of the most prevalent chronic liver diseases worldwide, with its incidence rising rapidly alongside the increasing prevalence of obesity and metabolic syndrome. At present, the treatment of NAFLD mainly relies on lifestyle intervention, but there is a lack of specific drugs. With in-depth research into the pathophysiological mechanisms of NAFLD, multiple drugs target metabolic disorders, inflammation, and fibrosis have become a hot topic. This article reviewed the latest advancements in NAFLD drug development, statistically analyzed global research trends and therapeutic hotspots, focused on introducing the clinical trial outcomes of metabolic modulators, anti-inflammatory or anti-fibrotic agents, and emerging targets, and discussed the future directions in this field.

non-alcoholic fatty liver disease  /  research and development of drug  /  drug target
陈丽娜, 马红玲, 王科冉, 张丽新, 斯日古楞. 非酒精性脂肪性肝病药物研发进展. 世界临床药物, 2025 , 46 (9) : 978 -983 . DOI: 10.13683/j.wph.2025.09.017
Li'na CHEN, Hongling MA, Keran WANG, Lixin ZHANG, Guleng Siri. Research progress on drug development for non-alcoholic fatty liver disease[J]. World Clinical Drug, 2025 , 46 (9) : 978 -983 . DOI: 10.13683/j.wph.2025.09.017
  • 公立医院科研联合基金科技项目(2023GLLH0047)
参考文献 引证文献
排序方式:
[1]
SCHAFFNER F, THALER H. Nonalcoholic fatty liver disease[J]. Prog Liver Dis, 1986, 8: 283-298.
[2]
ESLAM M, NEWSOME PN, SARIN SK, et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement[J]. J Hepatol, 2020, 73(1): 202-209.
[3]
ESLAM M, SANYAL AJ, GEORGE J. MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease[J]. Gastroenterology, 2020, 158(7): 1999-2014.
[4]
ESLAM M, SARIN SK, WONG VW, et al. The Asian Pacific Association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease[J]. Hepatol Int, 2020, 14(6):889-919.
[5]
RIAZI K, AZHARI H, CHARETTE JH, et al. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis[J]. Lancet Gastroenterol Hepatol, 2022, 7(9):851-861.
[6]
LE MH, LE DM, BAEZ TC, et al. Global incidence of non-alcoholic fatty liver disease: a systematic review and meta-analysis of 63 studies and 1, 201, 807 persons[J]. J Hepatol, 2023, 79(2): 287-295.
[7]
LOU TW, YANG RX, FAN JG. The global burden of fatty liver disease: the major impact of China[J]. Hepatobiliary Surg Nutr, 2024, 13(1): 119-123.
[8]
LOOMBA R, FRIEDMAN SL, SHULMAN GI. Mechanisms and disease consequences of nonalcoholic fatty liver disease[J]. Cell, 2021, 184(10): 2537-2564.
[9]
FLANNERY C, DUFOUR S, RABOL R, et al. Skeletal muscle insulin resistance promotes increased hepatic de novo lipogenesis, hyperlipidemia, and hepatic steatosis in the elderly[J]. Diabetes, 2012, 61(11): 2711-2717.
[10]
RABOL R, PETERSEN KF, DUFOUR S, et al. Reversal of muscle insulin resistance with exercise reduces postprandial hepatic de novo lipogenesis in insulin resistant individuals[J]. Proc Natl Acad Sci USA, 2011, 108(33): 13705-13709.
[11]
LEUNG C, RIVERA L, FURNESS JB, et al. The role of the gut microbiota in NAFLD[J]. Nat Rev Gastroenterol Hepatol, 2016, 13(7): 412-425.
[12]
赵丽, 罗娟, 陈晶. 肠道微生物群与非酒精性脂肪性肝病的最新研究进展[J]. 胃肠病学和肝病学杂志, 2020, 29(6):700-703.
[13]
DUELL PB, WELTY FK, MILLER M, et al. Nonalcoholic fatty liver disease and cardiovascular risk: a scientific statement from the American Heart Association[J]. Arterioscler Thromb Vasc Biol, 2022, 42(6): e168-e185.
[14]
段蓉, 李正翔. 国内外药物警戒研究现状与热点的文献计量学分析[J]. 中国药房, 2022, 33(1): 116-122.
[15]
董微, 闻育. 基于数据关联性聚类的数据布局算法[J]. 计算机工程与应用, 2014, (3): 117-120.
[16]
KHAZNADAR F, KHAZNADAR O, PETROVIC A, et al. MAFLD pandemic: Updates in pharmacotherapeutic approach development[J]. Curr Issues Mol Biol, 2024, 46(7): 6300-6314.
[17]
BERTHIER A, JOHANNS M, ZUMMO FP, et al. PPARs in liver physiology[J]. Biochim Biophys Acta Mol Basis Dis, 2021, 1867(5): 166097.
[18]
CUSI K, ORSAK B, BRIL F, et al. Long-term pioglitazone treatment for patients with nonalcoholic steatohepatitis and prediabetes or type 2 diabetes mellitus: a randomized trial[J]. Ann Intern Med, 2016, 165(5): 305-315.
[19]
VIOLI F, CANGEMI R. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis[J]. N Engl J Med, 2010,363(12): 1185-1186.
[20]
WANG Z, DU H, ZHAO Y, et al. Response to pioglitazone in non-alcoholic fatty liver disease patients with vs. without type 2 diabetes: a meta-analysis of randomized controlled trials[J]. Front Endocrinol(Lausanne), 2023, 14: 1111430.
[21]
JACQUES V, BOLZE S, HALLAKOU-BOZEC S, et al. Deuterium-stabilized(R)-pioglitazone(PXL065) is responsible for pioglitazone efficacy in NASH yet exhibits little to no PPARγ activity[J]. Hepatol Commun, 2021, 5(8):1412-1425.
[22]
Harrison SA, Thang C, Bolze S, et al. Evaluation of PXL065 -deuterium-stabilized (R)-pioglitazone in patients with NASH: a phase Ⅱ randomized placebo-controlled trial(DESTINY-1)[J]. J Hepatol, 2023, 78(5): 914-925.
[23]
BARB D, KALAVALAPALLI S, GODINEZ LEIVA E, et al. Pan-PPAR agonist lanifibranor improves insulin resistance and hepatic steatosis in patients with T2D and MASLD[J]. J Hepatol, 2025, 82(6): 979-991.
[24]
SOUZA M, AL-SHARIF L, ANTUNES VLJ, et al. Comparison of pharmacological therapies in metabolic dysfunction-associated steatohepatitis for fibrosis regression and MASH resolution: systematic review and network meta-analysis[J]. Hepatology, 2025, doi: 10.1097/HEP.0000000000001254.
[25]
LEFERE S, PUENGEL T, HUNDERTMARK J, et al. Differential effects of selective - and pan-PPAR agonists on experimental steatohepatitis and hepatic macrophages[J]. J Hepatol, 2020, 73(4): 757-770.
[26]
EVANS JL, LIN JJ, GOLDFINE ID. Novel approach to treat insulin resistance, type 2 diabetes, and the metabolic syndrome: simultaneous activation of PPARα, PPARγ, and PPARδ[J]. Curr Diabetes Rev, 2005, 1(3): 299-307.
[27]
XU HR, ZHANG JW, CHEN WL, et al. Pharmacokinetics, safety and tolerability of chiglitazar, a novel peroxisome proliferator-activated receptor(PPAR) pan-agonist, in healthy Chinese volunteers: a phase Ⅰ study[J]. Clin Drug Investig, 2019, 39(6): 553-563.
[28]
SHINOZAKI S, MIURA K, TAHARA T, et al. Effectiveness of pemafibrate dose escalation on metabolic dysfunction-associated steatotic liver disease refractory to standard dose[J]. Metabolites, 2025, 15(2): 100.
[29]
DUTTA D, KAMRUL-HASAN ABM, MONDAL E, et al. Role of resmetirom, a liver-directed, thyroid hormone receptor beta-selective agonist, in managing nonalcoholic steatohepatitis: a systematic review and meta-analysis[J]. Endocr Pract, 2024, 30(7): 631-638.
[30]
HARRISON SA, BEDOSSA P, GUY CD, et al. A phase 3, randomized, controlled trial of resmetirom in nash with liver fibrosis[J]. N Engl J Med, 2024, 390(6): 497-509.
[31]
AU K, ZHENG MH, LEE WJ, et al. Resmetirom and metabolic dysfunction-associated steatohepatitis: Perspectives on multidisciplinary management from global healthcare professionals[J]. Curr Obes Rep, 2024, 13(4): 818-830.
[32]
HAVRANEK B, LOH R, TORRE B, et al. Glucagon-like peptide-1 receptor agonists improve metabolic dysfunction-associated steatotic liver disease outcomes[J]. Sci Rep, 2025,15(1): 4947.
[33]
CORTES-MARTIN A, PLAZA-DIAZ J. Exploring the therapeutic potential of glucagon-like peptide 1 agonists in metabolic disorders[J]. World J Gastroenterol, 2025, 31(4):101436.
[34]
FORMAN BM, GOODE E, CHEN J, et al. Identification of a nuclear receptor that is activated by farnesol metabolites[J]. Cell, 1995, 81(5): 687-693.
[35]
MAKISHIMA M, OKAMOTO AY, REPA JJ, et al. Identification of a nuclear receptor for bile acids[J]. Science,1999, 284(5418): 1362-1365.
[36]
KAMRUL-HASAN A, MONDAL S, NAGENDRA L, et al. Role of obeticholic acid, a farnesoid X receptor agonist, in nonalcoholic fatty liver disease: a systematic review and meta-analysis[J]. touchREV Endocrinol, 2024, 20(2): 54-61.
[37]
MORADI MN, BEHROUJ H, ALIPOOR B, et al. Chlorella vulgaris is an effective supplement in counteracting non-alcoholic fatty liver disease-related complications through modulation of dyslipidemia, insulin resistance, and inflammatory pathways[J]. J Food Biochem, 2021, 45(10):e13914.
[38]
SITUMORANG JH, CHEN MC, KUO WW, et al. 9-POHSA prevents NF-κB activation and ameliorates LPS-induced inflammation in rat hepatocytes[J]. Lipids, 2023, 58(5):241-249.
[39]
JIN X, LIU L, ZHOU Z, et al. Pioglitazone alleviates inflammation in diabetic mice fed a high-fat diet via inhibiting advanced glycation end-product-induced classical macrophage activation[J]. FEBS J, 2016, 283(12): 2295-2308.
[40]
GEERVLIET E, KARKDIJK E, BANSAL R. Inhibition of intrahepatic monocyte recruitment by Cenicriviroc and extracellular matrix degradation by MMP1 synergistically attenuate liver inflammation and fibrogenesis in vivo[J]. Sci Rep, 2024, 14(1): 16897.
[41]
ZHOU M, LV J, CHEN X, et al. From gut to liver: Exploring the crosstalk between gut-liver axis and oxidative stress in metabolic dysfunction-associated steatotic liver disease[J]. Ann Hepatol, 2025, 30(1): 101777.
[42]
BELEI O, OLARIU L, DOBRESCU A, et al. The relationship between non-alcoholic fatty liver disease and small intestinal bacterial overgrowth among overweight and obese children and adolescents[J]. J Pediatr Endocrinol Metab, 2017,30(11): 1161-1168.
2025年第46卷第9期
54
12
0
引用本文
BibTeX
文章信息
doi: 10.13683/j.wph.2025.09.017
  • 接收时间:2025-03-14
  • 首发时间:2026-11-09
  • 出版时间:2025-09-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2025-03-14
基金
公立医院科研联合基金科技项目(2023GLLH0047)
作者信息
    内蒙古自治区人民医院药学处,内蒙古 呼和浩特 010017

通讯作者:

斯日古楞,主任药师,研究方向:临床药学及药事管理。
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2025.09.017
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏